Literature DB >> 10707255

Multiplex PCR assay to aid in the identification of the highly transmissible Mycobacterium tuberculosis strain CDC1551.

B B Plikaytis1, N Kurepina, C L Woodley, R Fleischmann, B Kreiswirth, T M Shinnick.   

Abstract

SETTING: Mycobacterium tuberculosis strain CDC1551 outbreak area in Tennessee and Kentucky and selected locations in the USA.
OBJECTIVE: Develop a PCR assay to distinguish the highly transmissible CDC1551 from strains which have similar 4-band IS6110 fingerprints.
DESIGN: Compare the IS6110 insertion sites in CDC1551 with those in 10 isolates which have similar 4-band IS6110 fingerprints. Utilize unique characteristics of insertion sites in CDC1551 to design a multiplex PCR to identify this strain.
RESULTS: A multiplex PCR was developed which targets an IS6110 insertion conserved in most IS6110 low copy number strains and a deletion within the direct repeat region adjacent to an IS6110 insertion. Of 139 isolates with similar 4-band fingerprints, the CDC1551 PCR pattern was generated by only the 14 outbreak associated isolates. Of 154 isolates with different fingerprints, only four generated the CDC1551 pattern and these could be distinguished from CDC1551 by their IS6110 fingerprint.
CONCLUSIONS: The multiplex PCR used in conjunction with the IS6110 fingerprint should be a useful tool to aid in the continued surveillance of the outbreak area and follow the spread of this highly transmissible strain of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10707255     DOI: 10.1054/tuld.1999.0197

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  7 in total

1.  Novel IS6110 insertion sites in the direct repeat locus of Mycobacterium tuberculosis clinical strains from the St. Petersburg area of Russia and evolutionary and epidemiological considerations.

Authors:  Igor Mokrousov; Olga Narvskaya; Elena Limeschenko; Tatiana Otten; Boris Vyshnevskiy
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units.

Authors:  Lauren Steinlein Cowan; Laura Mosher; Lois Diem; Jeffrey P Massey; Jack T Crawford
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Reverse dot blot assay (insertion site typing) for precise detection of sites of IS6110 insertion in the Mycobacterium tuberculosis genome.

Authors:  L M Steinlein; J T Crawford
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Genotype analysis of Mycobacterium tuberculosis isolates from a sentinel surveillance population.

Authors:  Lauren S Cowan; Jack T Crawford
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

5.  Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain.

Authors:  P Bifani; B Mathema; M Campo; S Moghazeh; B Nivin; E Shashkina; J Driscoll; S S Munsiff; R Frothingham; B N Kreiswirth
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

6.  Use of genome level-informed PCR as a new investigational approach for analysis of outbreak-associated Mycobacterium tuberculosis isolates.

Authors:  Kumar Rajakumar; Jamila Shafi; Rebecca J Smith; Richard A Stabler; Peter W Andrew; Deborah Modha; Gerry Bryant; Philip Monk; Jason Hinds; Philip D Butcher; Michael R Barer
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism.

Authors:  Agnese Serafini; Lendl Tan; Stuart Horswell; Steven Howell; Daniel J Greenwood; Deborah M Hunt; Minh-Duy Phan; Mark Schembri; Mercedes Monteleone; Christine R Montague; Warwick Britton; Acely Garza-Garcia; Ambrosius P Snijders; Brian VanderVen; Maximiliano G Gutierrez; Nicholas P West; Luiz Pedro S de Carvalho
Journal:  Mol Microbiol       Date:  2019-08-23       Impact factor: 3.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.